Atherosclerosis
Volume 191, Issue 1 , Pages 73-81 , March 2007

Vasa vasorum neovascularization and lesion distribution among different vascular beds in ApoE−/−/LDL−/− double knockout mice

  • Alexander C. Langheinrich

      Affiliations

    • Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Alfred 2-409, 200 First St SW, Rochester, MN 55905, USA
    • Department of Radiology, Justus-Liebig University Giessen, Germany
    • Authors contributed equally to the study.
  • ,
  • Agata Michniewicz

      Affiliations

    • Department of Radiology, Justus-Liebig University Giessen, Germany
  • ,
  • Rainer M. Bohle

      Affiliations

    • Department of Pathology, Justus-Liebig University Giessen, Germany
    • Authors contributed equally to the study.
  • ,
  • Erik L. Ritman

      Affiliations

    • Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Alfred 2-409, 200 First St SW, Rochester, MN 55905, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 507 255 1939; fax: +1 507 255 1935.

Received 31 January 2006 ,Revised 25 April 2006 ,Accepted 3 May 2006.

References 

  1. Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. Manifestations of atherosclerosis in various vascular regions. Similarities and differences regarding epidemiology, etiology and prognosis. Med Klin. 2002;97:221–228
  2. Sutton-Tyrrell K, Kuller LH, Matthews KA, et al. Subclinical atherosclerosis in multiple vascular beds: an index of atherosclerotic burden evaluated in postmenopausal women. Atherosclerosis. 2002;160:407–416
  3. Duvall WL, Vorchheimer DA. Multi-bed vascular disease and atherothrombosis: scope of the problem. J Thromb Thrombolysis. 2004;17:51–61
  4. Pasterkamp G, Schoneveld AH, Hillen B, et al. Is plaque formation in the common carotid artery representative for plaque formation and luminal stenosis in other atherosclerotic peripheral arteries? A post mortem study. Atherosclerosis. 1998;137:205–210
  5. Weber G, Bianciardi G, Bussani R, et al. Atherosclerosis and aging. A morphometric study on arterial lesions of elderly and very elderly necropsy subjects. Arch Pathol Lab Med. 1988;112:1066–1070
  6. Galili O, Herrmann J, Woodrum J, et al. Adventitial vasa vasorum heterogeneity among different vascular beds. J Vasc Surg. 2004;40:529–535
  7. Galili O, Sattler KJ, Herrmann J, et al. Experimental hypercholesterolemia differentially affects adventitial vasa vasorum and vessel structure of the left internal thoracic and coronary arteries. J Thorac Cardiovasc Surg. 2005;129:767–772
  8. Reardon CA, Blachowicz L, Lukens J, Nissenbaum M, Getz GS. Genetic background selectively influences innominate artery atherosclerosis: immune system deficiency as a probe. Arterioscler Thromb Vasc Biol. 2003;23:1449–1454
  9. McGill HC, McMahan CA, Herderick EE, et al. Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol. 2000;20:836–845
  10. Dai G, Kaazempur-Mofrad MR, Natarajan S, et al. Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature. Proc Natl Acad Sci USA. 2004;101:14871–14876
  11. Davies PF, Shi C, Depaola N, Helmke BP, Polacek DC. Hemodynamics and the focal origin of atherosclerosis: a spatial approach to endothelial structure, gene expression, and function. Ann NY Acad Sci. 2001;947:7
  12. Langheinrich AC, Michniewicz A, Sedding DG, et al. Correlation of vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(−/−)/low-density lipoprotein(−/−) double knockout mice. Arterioscler Thromb Vasc Biol. 2006;26:347–352
  13. Galili O, Herrmann J, Woodrum J, et al. Adventitial vasa vasorum heterogeneity among different vascular beds. J Vasc Surg. 2004;40:529–535
  14. Barger AC, Beeuwkes R, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med. 1984;310:175–177
  15. Moulton KS, Heller E, Konerding MA, et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation. 1999;99:1726–1732
  16. Moulton KS, Vakili K, Zurakowski D, et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA. 2003;100:4736–4741
  17. Ritman EL, Jorgensen SM, Lund PE, et al. Synchrotron-based micro-CT of in situ biological basic functional units and their integration. Proc SPIE, Dev X-Ray Tomogr. 1997;3149:13–24
  18. Jorgensen SM, Demirkaya O, Ritman EL. Three-dimensional imaging of vasculature and parenchyma in intact rodent organs with X-ray micro-CT. Am J Physiol. 1998;275:H1103–H1114
  19. Langheinrich AC, Bohle RM, Breithecker A, Lommel D, Rau WS. Micro-computed tomography of the vasculature in parenchymal organs and lung alveoli. Rofo. 2004;176:1219–1225
  20. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995;92:1355–1374
  21. Langheinrich AC, Bohle RM. Atherosclerosis: humoral and cellular factors of inflammation. Virchows Arch. 2005;446:101–111
  22. Park DS, Cohen AW, Frank PG, et al. Caveolin-1 null (−/−) mice show dramatic reductions in life span. Biochemistry. 2003;42:15124–15131
  23. Moghadasian MH, McManus BM, Nguyen LB, et al. Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans. FASEB J. 2001;15:2623–2630
  24. Hu W, Polinsky P, Sadoun E, Rosenfeld ME, Schwartz SM. Atherosclerotic lesions in the common coronary arteries of ApoE knockout mice. Cardiovasc Pathol. 2005;14:120–125
  25. Schutte HE. Plaque localization and distribution of vasa vasorum. A micro-angiological study of the human abdominal aorta. Angiologica. 1966;3:21–39
  26. Cheng TO. Why is atherosclerosis non-existent in human intramyocardial coronary arteries?. Atherosclerosis. 2000;153:259
  27. Scher AM. Absence of atherosclerosis in human intramyocardial coronary arteries: a neglected phenomenon. Atherosclerosis. 2000;149:1–3
  28. Okuyama S, Okuyama J, Okuyama J, et al. The arterial circle of Willis of the mouse helps to decipher secrets of cerebral vascular accidents in the human. Med Hypotheses. 2004;63:997–999
  29. Sollberg LA, McGarry PA, Moossy J, et al. Severity of atherosclerosis in cerebral arteries, coronary arteries, and aortas. Ann NY Acad Sci. 1968;149:956–973
  30. Weber G, Bianciardi G, Bussani R, et al. Atherosclerosis and aging. A morphometric study on arterial lesions of elderly and very elderly necropsy subjects. Arch Pathol Lab Med. 1988;112:1066–1070
  31. Vink A, Schoneveld AH, Poppen M, et al. Morphometric and immunohistochemical characterization of the intimal layer throughout the arterial system of elderly humans. J Anat. 2002;200:97–103
  32. Werber AH, Armstrong ML, Heistad DD. Diffusional support of the thoracic aorta in atherosclerotic monkeys. Atherosclerosis. 1987;68:123–130
  33. Williams JK, Armstrong ML, Heistad DD. Vasa vasorum in atherosclerotic coronary arteries: responses to vasoactive stimuli and regression of atherosclerosis. Circ Res. 1988;62:515–523
  34. Heistad DD, Marcus ML, Larsen GE, Armstrong ML. Role of vasa vasorum in nourishment of the aortic wall. Am J Physiol. 1981;240:H781–H787
  35. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13:2–9
  36. Helmchen U, Bohle RM, Kneissler U, Groene HJ. Intrarenal arteries in rats with early two-kidney, one clip hypertension. Hypertension. 1984;6:III87–III92
  37. Helmchen U, Kneissler U, Bohle RM, Reher A, Groene HJ. Adaptation and decompensation of intrarenal small arteries in experimental hypertension. J Cardiovasc Pharmacol. 1984;6(Suppl 4):S696–S705

PII: S0021-9150(06)00263-2

doi: 10.1016/j.atherosclerosis.2006.05.021

Atherosclerosis
Volume 191, Issue 1 , Pages 73-81 , March 2007